prevexxion rn
boehringer ingelheim vetmedica gmbh - live recombinant marek’s disease (md) virus, serotype 1, strain rn1250 - immunoloogilised ained - kana - for active immunisation of one-day-old chicks to prevent mortality and clinical signs and reduce lesions caused by marek’s disease (md) virus (including very virulent md virus).
ultifend nd ibd
ceva-phylaxia veterinary biologicals co. ltd - turkey herpes virus, strain rhvt/nd/ibd, expressing the fusion protein of newcastle disease virus and the vp2 protein of infectious bursal disease virus, live recombinant - immunoloogilised ained - embryonated chicken eggs; chicken - for the active immunisation of one-day-old chicks or 18-day-old chicken embryonated eggs to reduce mortality, clinical signs and lesions caused by newcastle disease virus (ndv) and to reduce virus shedding; to reduce mortality, clinical signs and bursa lesions caused by very virulent infectious bursal disease virus (ibdv); to reduce mortality, clinical signs and lesions caused by classical marek’s disease virus (mdv).
nobivac dp plus
intervet international b.v. - live attenuated canine distemper virus strain onderstepoort: 105.1 – 106.5 tcid50, live recombinant canine parvovirus strain 630a: 105.1 – 106.7 tcid50 - immuunväetised koertel - dogs (small) - for the active immunisation of puppies from 4 weeks of age onwards to prevent clinical signs and mortality of canine distemper virus infection and canine parvovirus infection and to prevent viral excretion following canine distemper virus infection and following canine parvovirus infection.
vidprevtyn beta
sanofi pasteur - sars-cov-2 prefusion spike delta tm protein, recombinant (b.1.351 strain) - covid-19 virus infection - vaktsiinid - vidprevtyn beta is indicated as a booster for active immunisation to prevent covid-19 in adults who have previously received an mrna or adenoviral vector covid-19 vaccine (see sections 4. 2 ja 5. 1 in product information document). kasutamist see vaktsiin peaks olema kooskõlas ametlike soovitustega.
bimervax
hipra human health s.l. - sars-cov-2 virus recombinant spike (s) protein receptor binding domain (rbd) fusion heterodimer – b.1.351-b.1.1.7 strains - covid-19 virus infection - vaktsiinid - bimervax is indicated as a booster for active immunisation to prevent covid-19 in individuals 16 years of age and older who have previously received a mrna covid-19 vaccine.
alpheon
biopartners gmbh - recombinant human interferon alfa-2a - c-hepatiit, krooniline - immunostimulants, - adult patients with histologically proven chronic hepatitis c who are positive for hepatitis c virus (hcv) antibodies or hcv rna and have elevated serum alanine aminotransferase (alt) without liver decompensation. the efficacy of interferon alfa-2a in the treatment of hepatitis c is enhanced when combined with ribavirin. alpheon should be given alone mainly in case of intolerance or contra-indication to ribavirin.
presucomb 5mg/10mg kõvakapsel
pharmaswiss ceska republika s.r.o. - ramipriil+amlodipiin - kõvakapsel - 5mg+10mg 90tk; 5mg+10mg 100tk; 5mg+10mg 60tk; 5mg+10mg 28tk; 5mg+10mg 91tk; 5mg+10mg 32tk
presucomb 10mg/10mg kõvakapsel
pharmaswiss ceska republika s.r.o. - ramipriil+amlodipiin - kõvakapsel - 10mg+10mg 32tk; 10mg+10mg 28tk; 10mg+10mg 60tk; 10mg+10mg 96tk; 10mg+10mg 100tk; 10mg+10mg 90tk; 10mg+10mg 56tk; 10mg+10mg 30tk
presucomb 2,5mg/5mg kõvakapsel
pharmaswiss ceska republika s.r.o. - ramipriil+amlodipiin - kõvakapsel - 2,5mg+5mg 56tk; 2,5mg+5mg 28tk; 2,5mg+5mg 96tk; 2,5mg+5mg 91tk; 2,5mg+5mg 100tk; 2,5mg+5mg 30tk; 2,5mg+5mg 60tk; 2,5mg+5mg 98tk
presucomb 10mg/5mg kõvakapsel
pharmaswiss ceska republika s.r.o. - ramipriil+amlodipiin - kõvakapsel - 10mg+5mg 28tk; 10mg+5mg 98tk; 10mg+5mg 96tk; 10mg+5mg 30tk; 10mg+5mg 60tk